Introduction: With the adoption of routine screening mammography, breast cancers are being diagnosed at earlier stages, with DCIS now accouting for 22.5% of all newly diagnosed breast cancers. This has been attributed to both increased breast cancer awareness and improvements in breast imaging techniques. How have these changes, including the increased use of image-guided sampling techniques, infl uenced the clinical practice of breast surgery?
Introduction
With the widespread use of breast cancer screening by mammography in the industrialized world, breast cancers are being diagnosed at increasingly earlier stages. In national surveys, approximately 75% of American women 40 years of age and older report having undergone mammography within the last two years (Smigal et al. 2006; Ryerson et al. 2007 ). Currently ductal carcinoma in situ accounts for 22.5% of newly diagnosed breast cancers (Smigal et al. 2006) , while in 1990, it accounted for only 2% of all newly diagnosed breast cancers (Adamovich and Simmons, 2003; Esserman, 2006) . The American Cancer Society estimates that approximately 212,920 new cases of invasive breast cancer, and 61,980 cases of in situ disease would be diagnosed in the United States in the year 2006 (Smigal et al. 2006) . This shift has additionally been attributed to improvements in breast imaging techniques, including the increased use of image-guided sampling techniques, and most recently, the use of magnetic resonance imaging (MRI) evaluation of the breast (Goethem et al. 2006 ).
In addition, surgical practice has changed dramatically as well over the last decade, particularly with the widespread adoption of the sentinel node technique for axillary staging (Kim et al. 2005) , and refi nements in breast reconstruction techniques.
How have these changes infl uenced the clinical practice of breast surgery? We reviewed our institutional experience over a 10 year interval, a period in which both radiologic evaluation and clinical management of breast disease has undergone signifi cant change.
Methods
The institutional pathology database was queried for all breast surgeries (including breast reconstruction) performed in the years 1995 and 2005. Cosmetic procedures were excluded. The year 1995 was chosen as it was before sentinel node biopsy became the standard of care for axillary staging in early-stage breast cancer, while 2005 was the most recent year for which we had complete data.
The variables examined included year of surgery, patient age, preoperative diagnosis, surgical procedure performed, and pathology results. For patients undergoing simultaneous but unrelated procedures, each procedure was tabulated separately, and the pathology results evaluated separately as well. For patients with invasive ductal carcinoma (IDC) with a component of DCIS, they were tabulated as IDC. Cases of DCIS with microinvasion were included in the DCIS group. The results were tabulated on an Excel spreadsheet, and analyzed utilizing the Chi-square test.
Institutional Review Board approval was granted.
Results

Surgical indications
Indications for breast surgery changed signifi cantly over the 10-year study period, with an increased incidence of pre-operatively diagnosed cancers undergoing defi nitive surgical management, rising from 32.4% in 1995 to 39.8% in 2005. ADH, and to a lesser extent, ALH, became indications for surgical excision. Fewer surgical biopsies were performed for indeterminate abnormalities on breast imaging, decreasing from 34.2% to 16.8%. The results are summarized in Table 1 .
There was no signifi cant change in the rate of biopsies performed for a palpable mass, or in the rate of benign biopsies (42.3% vs. 41.1%).
There was no signifi cant change in the percentage of biopsies performed for abnormal or indeterminate fi ndings on fi ne needle aspiration cytology.
Surgical procedures
The rate of mastectomy dropped, from 36.8% in 1995 to 14.5% in 2005. Accompanying the increase in sentinel node procedures, the rate of axillary lymph node dissection (ALND) dropped significantly. In 1995, only 6 of 127 patients (4.8%) were evaluated for axillary metastases using the sentinel node technique. By 2005, 246 (64%) of 384 patients were staged solely with sentinel lymphadenectomy. Accompanying the increased recognition of early-stage cancers, the rate of positive axillary staging also decreased signifi cantly, from 43.3% to 25%. Elderly, frail patients, and those with signifi cant life-threatening co-morbidities, did not undergo axillary staging.
In 1995, 60 breast reconstructions were performed. All 20 autologous tissue transfer cases were pedicled transverse rectus abdominis myocutaneous (TRAM) fl aps, and the remaining 40 patients underwent implant procedures. In 2005, 35 autologous tissue breast reconstructions were performed (31 TRAM fl aps with microvascular reanastomoses and 4 pedicled TRAM fl aps) and 80 implant procedures.
Pathology
There was a higher incidence of DCIS cases in 2005, increasing from 23.4% in 1995 to 32.0%. The incidence of lobular carcinoma in situ (LCIS) was not signifi cantly different in the two index years, probably due to the fact that in the majority of cases, LCIS is still a serendipitous fi nding, due to its occult nature on both clinical and radiologic evaluation. The incidence of all other pathologic diagnoses was essentially unchanged.
The rate of benign breast biopsies remained constant, with 141 of these lesions being fi broadenomas in 1995 (71%), and 256 fi broadenomas in 2005 (73%).
Radiology
By 2005, digital mammography was replacing analog mammography. With increasing frequency, Magnetic Resonance Imaging examinations (MRI) were used for high-risk screening and surgical planning, but had not yet been adopted as routine studies. The use of image-guided biopsies changed over the 10-year period (Table 2) , with increases in the use of both ultrasound-guided fi ne needle aspiration (FNA) biopsies and core biopsies. Large-bore Mammotome™ biopsies largely supplanted stereotactic fi ne-needle aspiration biopsy for the evaluation of mammographic abnormalities.
By 2005, the vast majority of core biopsies were performed under image-guidance by radiologists. The core biopsies performed by the surgeons were either offi ce procedures for diagnosis of a palpable mass, or in women with locally-advanced cancers who were candidates for neoadjuvant therapy, to obtain biomarkers.
Surgeon-operated intraoperative ultrasound has not been routinely used in the institution. 
Discussion
With increased awareness and availability of routine breast cancer screening, breast cancers are being diagnosed at earlier stages. Currently, over 70% of all newly diagnosed breast cancers in the United States are Stages 0-2 (van de Vijver, 2005; Smigal et al. 2006) .
Accompanying this are major technologic changes in breast imaging. Digital mammography is quickly becoming the standard of care, especially in the evaluation of premenopausal women (Pisano et al. 2005) . When compared to fi lm mammography, digital mammography has been found to be more accurate in women under the age of 50 years, in women with radiologically dense breasts, and in pre/perimenopausal women.
The widespread adoption of large-bore needle image-guided biopsy techniques has had a major impact on how breast cancers are diagnosed. Rather than undergoing an initial diagnostic surgical procedure, increasingly patients go to the operating room with a histologic diagnosis of a high-risk or malignant lesion (Liberman, 1999; Crowe et al. 2002) . Crowe et al. (10) reported on the experience at the Cleveland Clinic from 1995 to 2000. During that time, the percentage of diagnostic breast biopsies performed as image-guided core biopsies rather than surgical biopsies increased from 31% to 68%. A similar change is refl ected in our data (Tables 1&2). Within the last few years the role of breast MRI has become better defi ned. In particular, it is now being used for surgical planning in the setting of a known breast cancer, both to evaluate the extent of known disease, and for the detection of multifocal, multicentric, and contralateral malignancies (Goethem et al. 2006 ) (Lehman et al. 2007 ). It appears that tumor diameter measured on MRI correlates more closely with the histologic measurements, compared to the diameters measured on mammography and ultrasound. Thus, it is being increasingly used in planning for breastconserving therapy.
Indications for surgery
Over this ten-year period the indications for breast surgery changed, shifting away from diagnostic procedures to therapeutic interventions. This is refl ected by the decreased rate of procedures being performed for abnormal mammographic fi ndings, from 32.4% in 1995 to 16.8% in 2005 , and the increase in preoperative diagnoses of breast cancer or pre-malignant lesions such as ADH/ALH from 32.4% in 1995 to 43.1% in 2005. (Masetti et al. 2006) . The increase in BCT may also be infl uenced by the use of preoperative MRI-perhaps patients (and surgeons) are more comfortable with the decision to proceed with breast conservation when an MRI has revealed no additional suspicious lesions in either breast. The increase in sentinel node procedures refl ects that this technique has supplanted the diagnostic axillary dissection for routine staging of the axilla in early stage breast cancer.
Pathology
Interestingly, the rate of benign biopsies was similar in both years. The preoperative evaluation, and indications for surgical removal of presumed benign lesions in young women, did not change appreciably during the study period, and this may explain the constant rate of benign biopsy.
When considering the ADH/ALH group, the fi nal surgical pathology results maybe somewhat misleading for this group. With the increase in image-guided diagnostic core biopsies, we are seeing more cases of minimal volume disease in which all involved tissue has been removed by the large bore vacuum-assisted biopsies, with no residual atypia on the subsequent surgical excision. This may explain the decrease in rate of ADH/ALH in surgical specimens in 2005 (personal communication, Baljit Singh).
Conclusions
The surgical management of breast disease has changed signifi cantly in our institution during the last decade, refl ecting the widespread refi nements in breast cancer diagnosis and management. The management of breast disease has shifted from generalists to dedicated surgical oncologists and breast pathologists.
While the rate of benign breast biopsies has remained constant, more pre-invasive lesions and Stage 0 cancers are undergoing surgical management. A greater percentage of patients with breast disease have their diagnoses determined before surgery. Earlier stage invasive cancers are being detected, refl ected by the lower incidence of axillary nodal metastases. Sentinel node biopsy has supplanted diagnostic axillary dissection Correspondingly there has been a greater shift towards breast conserving therapy.
